Nuclear Receptor Coregulators and Human Disease
- 1 August 2007
- journal article
- review article
- Published by The Endocrine Society in Endocrine Reviews
- Vol. 28 (5), 575-587
- https://doi.org/10.1210/er.2007-0012
Abstract
Nuclear receptor (NR) coregulators (coactivators and corepressors) are essential elements in regulating nuclear receptor-mediated transcription. In a little more than a decade since their discovery, these proteins have been studied mechanistically and reveal that the regulation of transcription is a highly controlled and complex process. Because of their central role in regulating NR-mediated transcription and in coordinating intercompartmental metabolic processes, disruptions in coregulator biology can lead to pathological states. To date, the extent to which they are involved in human disease has not been widely appreciated. In a complete literature survey, we have identified nearly 300 distinct coregulators, revealing that a great variety of enzymatic and regulatory capabilities exist for NRs to regulate transcription and other cellular events. Here, we substantiate that coregulators are broadly implicated in human pathological states and will be of growing future interest in clinical medicine.Keywords
This publication has 109 references indexed in Scilit:
- Oncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic programProceedings of the National Academy of Sciences of the United States of America, 2006
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- A haplotype map of the human genomeNature, 2005
- Mining for regulatory programs in the cancer transcriptomeNature Genetics, 2005
- Calorie restriction, SIRT1 and metabolism: understanding longevityNature Reviews Molecular Cell Biology, 2005
- Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibresNature, 2002
- Anti‐tumor mechanisms of valproate: A novel role for an old drugMedicinal Research Reviews, 2002
- De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndromeNature Genetics, 1997
- A transcriptional co-repressor that interacts with nuclear hormone receptorsNature, 1995